查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375963

血流传染病检查市场规模、份额、趋势分析报告：按产品类型、按样本类型、按技术、按最终用途、按地区、按细分市场、预测，2023-2030 年

Bloodstream Infection Testing Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Sample Type (Blood Culture), By Technology (PCR, ISH), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

血流传染病检查市场成长与趋势：

Grand View Research, Inc.最新研究显示，预计到2030年，全球血流传染病检查市场规模将达到9.7757亿美元，年复合成长率为4.5%。

全球感染疾病数量的增加、人们对感染控制的认识不断提高以及对感染控制的重视是推动市场发展的一些关键因素。例如，根据欧洲疾病预防控制中心（ECDC）2022年4月进行的流行病学调查，欧洲各地的耳念珠菌病例明显增加。研究显示，耳念珠菌报告病例显着增加，从 2020 年 8 个国家报告的 335 例增加到 2021 年 13 个国家报告的 655 例。 2021 年报告的病例中有 15.3% 是血流感染疾病。

此外，市场主要企业不断进步的技术进步和新产品的推出、政府的鼓励配合措施以及对捐血重要性的认识不断提高预计将推动市场成长。例如，2020 年 4 月。次世代定序仪公司 DNAe 因其创新的 LiDia-SEQ 平台和首次检测获得了美国食品药物管理局(FDA) 的突破性设备称号。这项指定将使 DNAe 能够开发快速、经济高效的检测方法，用于感染疾病诊断、癌症、感染控制以及大流行的防范和应对。指定的检测方法着重于感染疾病，特别是血流感染疾病（BSI）和抗菌素抗药性（AMR），旨在直接从患者检体中检测和识别脓毒症相关感染疾病。这就是我的意思。透过突破性设备计划，FDA 将提供持续的支援和协作互动，以加速 DNAe 的 LiDia-SEQ 定序系统和 BSI/AMR 测试的开发和商业化。

F. Hoffmann-La Roche Ltd、bioMerieux SA 和 BD 等市场主要企业正在实施併购策略，以增强其产品能力并加速其产品供应。例如，2021年5月，F. Hoffmann-La Roche Ltd以18亿美元收购了GenMark Diagnostics。此次收购将扩大罗氏分子诊断产品的组合。同样，2021年12月，该公司收购了TIB Molbiol Group。 TIB Molbiol 集团拥有约 45 种 CE-IVD核准的血液学检测、遗传基因检测、感染疾病诊断和移植医学检测方法。

血流传染病检查市场报告亮点

  • 按产品划分，2022年试剂和消耗品领域占市场最大销售份额。由于捐赠者和接受者容易取得且频繁购买筛检产品，预计该细分市场在预测期内将以最快的速度成长。
  • 根据样本类型，血液培养领域预计将在 2022 年占据最大的收益占有率，并在预测期内实现最快的年复合成长率。
  • 从技术角度来看，由于检测需求不断增加，PCR 领域预计将在 2022 年占据市场最大的收益占有率，并在预测期内以最快的年复合成长率成长。
  • 按最终用途划分，医院和诊断中心细分市场在 2022 年占据最大收益占有率。
  • 北美主导了血流传染病检查市场，在 2022 年占据了最大的收益占有率。这是由于该地区可支配所得不断增加、医疗基础设施高度发展以及有利的报销政策。

目录

第1章调查方法与范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第4章传染病检查市场：产品业务分析

  • 血流传染病检查市场：产品变异分析
  • 装置
  • 试剂及消耗品

第5章传染病检查市场：样本类型的商业分析

  • 血流传染病检查市场：样本类型变异分析
  • 全血
  • 血液培养

第6章传染病检查市场：技术业务分析

  • 血流传染病检查市场：技术波动分析
  • PCR
  • 质谱
  • 原位杂交
  • 其他的

第7章传染病检查市场：最终用户业务分析

  • 血流传染病检查市场：最终用户波动分析
  • 医院和诊断中心
  • 客製化实验室服务提供商
  • 学术研究所
  • 其他的

第8章传染病检查市场：区域业务分析

  • 2022 年和 2030 年按地区分類的血流传染病检查市场占有率
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章传染病检查市场：竞争形势

  • 参与企业
  • 参与企业概况
  • 2022 年公司市场占有率分析
  • 策略规划

第10章分析师的观点

Product Code: GVR-4-68040-140-3

Bloodstream Infection Testing Market Growth & Trends:

The global bloodstream infection testing market size is expected to reach USD 977.57 million by 2030, registering at a CAGR of 4.5%, according to a new study by Grand View Research, Inc. The increasing number of infectious diseases globally and the growing awareness and emphasis on infection control are some of the major factors driving the market. For Instance, according to an epidemiologic survey organized by the European Centre for Disease Prevention and Control (ECDC) in April 2022, there was a notable increase in Candida auris cases across the European region. The survey revealed a significant rise in reported cases of C. auris, from 335 cases reported by 8 countries in 2020 to 655 cases reported by 13 countries in 2021. Bloodstream infections accounted for 15.3% of the reported cases in 2021.

In addition, increasing technological advancements and new product launches by key companies in the market, encouraging government initiatives, and increasing awareness about the importance of blood donation are expected to propel market growth. For instance, in April 2020. DNAe, a next-generation sequencing company, has received a "Breakthrough Device" designation from the U.S. Food and Drug Administration (FDA) for its innovative LiDia-SEQ platform and first assay. This designation enables DNAe to develop rapid and cost-effective tests for infectious disease diagnostics, cancer, infection control, and pandemic preparedness and response. The designated assay focuses on infectious diseases, specifically bloodstream infections (BSI) and antimicrobial resistance (AMR), aiming to detect and identify infections associated with sepsis directly from patient specimens. Through the Breakthrough Device program, the FDA will provide ongoing support and collaborative interactions to facilitate the development and launch of DNAe's LiDia-SEQ sequencing system and BSI/AMR test.

The key players in the market, such as F. Hoffmann-La Roche Ltd., bioMerieux SA, BD, etc., are implementing the strategy of merger & acquisition to enhance product capabilities and promote their product offerings. For instance, in May 2021, F. Hoffmann-La Roche Ltd. completed the acquisition of GenMark Diagnostics for USD 1.8 billion. This acquisition would help Roche expand its molecular diagnostics portfolio. Similarly, in December 2021, the company acquired TIB Molbiol Group, which has around 45 CE-IVD-approved assays for hematology testing, inherited genetic testing, diagnosing infectious diseases, and transplant medicine.

Bloodstream Infection Testing Market Report Highlights:

  • Based on the product, the reagents and consumables segment accounted for the largest revenue share of the market in 2022. The segment is also expected to grow at the fastest rate over the forecast period owing to the easy availability and frequent purchase of screening products for donors and recipients
  • Based on sample type, the blood culture segment accounted for the largest revenue share in 2022 and is expected to witness the fastest CAGR over the forecast period
  • Based on technology, the PCR segment held the largest revenue share of the market in 2022 and is expected to grow with the fastest CAGR over the forecast period owing to increasing demand for the tests
  • Based on end-user, the hospital and diagnostic centers segment accounted for the largest revenue share in 2022
  • North America dominated the bloodstream infection testing market and accounted for the largest revenue share in 2022. This is due to the region's Increasing disposable income, highly developed health infrastructure, and favorable reimbursement policies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Sample Type segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Technology segment
      • 1.1.1.4. End-use segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product and Sample Type Snapshot
  • 2.3. Technology and End-use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of infectious diseases
      • 3.2.1.2. Technological advancements in bloodstream infection testing
      • 3.2.1.3. Growing initiatives for blood donations campaign
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High diagnosis cost and lower investments in underdeveloped countries
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bloodstream Infection Testing Market: Product Business Analysis

  • 4.1. Bloodstream Infection Testing Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Reagents and Consumables
    • 4.3.1. Reagents and Consumables Market, 2018 - 2030 (USD Million)

Chapter 5. Bloodstream Infection Testing Market: Sample Type Business Analysis

  • 5.1. Bloodstream Infection Testing Market: Sample Type Movement Analysis
  • 5.2. Whole Blood
    • 5.2.1. Whole Blood Market, 2018 - 2030 (USD Million)
  • 5.3. Blood Culture
    • 5.3.1. Blood Culture Market, 2018 - 2030 (USD Million)

Chapter 6. Bloodstream Infection Testing Market: Technology Business Analysis

  • 6.1. Bloodstream Infection Testing Market: Technology Movement Analysis
  • 6.2. PCR
    • 6.2.1. PCR Market, 2018 - 2030 (USD Million)
  • 6.3. Mass Spectroscopy
    • 6.3.1. Mass Spectroscopy Market, 2018 - 2030 (USD Million)
  • 6.4. In Situ Hybridization
    • 6.4.1. In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Bloodstream Infection Testing Market: End-User Business Analysis

  • 7.1. Bloodstream Infection Testing Market: End-User Movement Analysis
  • 7.2. Hospitals & Diagnostic Centers
    • 7.2.1. Hospitals & Diagnostics Centers Market, 2018 - 2030 (USD Million)
  • 7.3. Custom Laboratory Service Providers
    • 7.3.1. Custom Laboratory Service Providers Market, 2018 - 2030 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Bloodstream Infection Testing Market: Regional Business Analysis

  • 8.1. Bloodstream Infection Testing Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. U.S. Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Canada Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. Reimbursement Scenario
      • 8.3.2.6. UK Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. France Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. Italy Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Spain Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Denmark Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Sweden Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Norway Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. Australia Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. Thailand Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. South Korea Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Reimbursement Scenario
      • 8.5.2.6. Brazil Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Mexico Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Reimbursement Scenario
      • 8.5.4.6. Argentina Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Reimbursement Scenario
      • 8.6.2.6. South Africa Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. Saudi Arabia Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. UAE Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. Kuwait Bloodstream Infection Testing Market, 2018 - 2030 (USD Million)

Chapter 9. Bloodstream Infection Testing Market: Competitive Landscape

  • 8.1. Participant Categorization
    • 9.1.1. bioMerieux SA
      • 9.1.1.1. Overview
      • 9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.1.3. Product Benchmarking
      • 9.1.1.4. Strategic Initiatives
    • 9.1.2. BD
      • 9.1.2.1. Overview
      • 9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.2.3. Product Benchmarking
      • 9.1.2.4. Strategic Initiatives
    • 9.1.3. Cepheid
      • 9.1.3.1. Overview
      • 9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.3.3. Product Benchmarking
      • 9.1.3.4. Strategic Initiatives
    • 9.1.4. Seegene Inc.
      • 9.1.4.1. Overview
      • 9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.4.3. Product Benchmarking
      • 9.1.4.4. Strategic Initiatives
    • 9.1.5. T2 Biosystems, Inc.
      • 9.1.5.1. Overview
      • 9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.5.3. Product Benchmarking
      • 9.1.5.4. Strategic Initiatives
    • 9.1.6. F. Hoffmann-La Roche Ltd
      • 9.1.6.1. Overview
      • 9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.6.3. Product Benchmarking
      • 9.1.6.4. Strategic Initiatives
    • 9.1.7. Siemens Healthcare Limited
      • 9.1.7.1. Overview
      • 9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.7.3. Product Benchmarking
      • 9.1.7.4. Strategic Initiatives
    • 9.1.8. Luminex Corporation
      • 9.1.8.1. Overview
      • 9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.8.3. Product Benchmarking
      • 9.1.8.4. Strategic Initiatives
    • 9.1.9. Bruker
      • 9.1.9.1. Overview
      • 9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.9.3. Product Benchmarking
      • 9.1.9.4. Strategic Initiatives
    • 9.1.10. Accelerate Diagnostics, Inc.
      • 9.1.10.1. Overview
      • 9.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.10.3. Product Benchmarking
      • 9.1.10.4. Strategic Initiatives
  • 9.2. Participant's Overview
  • 9.3. Financial Performance
  • 9.4. Product Benchmarking
  • 9.5. Company Market Share Analysis, 2022
  • 9.6. Strategy Mapping
    • 9.6.1. Expansion
    • 9.6.2. Acquisition
    • 9.6.3. Product/Service Launch
    • 9.6.4. Others

Chapter 10. Analyst View

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Bloodstream Infection Testing Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Bloodstream Infection Testing Market, By Sample type, 2018 - 2030 (USD Million)
  • Table 5 Global Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Bloodstream Infection Testing Market, By End-user, 2018 - 2030 (USD Million)
  • Table 7 Global Bloodstream Infection Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Bloodstream Infection Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Bloodstream Infection Testing Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Bloodstream Infection Testing Market, By Sample type, 2018 - 2030 (USD Million)
  • Table 11 North America Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 17 Canada Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 19 Canada Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 20 Canada Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD million)
  • Table 21 Europe Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 24 Europe Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 25 Europe Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 UK Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 27 UK. Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 28 UK Bloodstream Infection Testing Market, By Technology, 2018 - 2030 (USD Million)
  • Table 29 UK Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 Germany Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 32 Germany Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 33 Germany Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 France Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 35 France Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 36 France Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 France Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Italy Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Italy Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 40 Italy Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Italy Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Spain Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Spain Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 44 Spain Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 45 Spain Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 46 Denmark Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Denmark Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Denmark Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Sweden Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Sweden Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Sweden Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 Norway Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Norway Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 56 Norway Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Norway Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 Japan Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Japan Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 65 Japan Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Japan Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 China Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 68 China Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 69 China Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 China Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 India Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 72 India Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 73 India Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 India Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 75 Australia Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 76 Australia Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 77 Australia Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Australia Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 79 Thailand Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 80 Thailand Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 81 Thailand Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Thailand Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 83 South Korea Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 84 South Korea Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 85 South Korea Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Korea Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Latin America Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Latin America Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 90 Latin America Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 Latin America Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 92 Brazil Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Brazil Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 94 Brazil Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Brazil Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 96 Mexico Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Mexico Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 99 Mexico Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Argentina Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Bloodstream Infection Testing market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 112 South Africa Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 117 UAE Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 119 UAE Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 120 UAE Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Bloodstream Infection Testing market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Bloodstream Infection Testing market, by Sample type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Bloodstream Infection Testing market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Bloodstream Infection Testing market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Microscope software, market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT analysis
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Global bloodstream infection testing market: product movement & market share analysis.
  • Fig. 16 Global bloodstream infection testing market, for reagents and consumables, 2018 - 2030 (USD Million)
  • Fig. 17 Global bloodstream infection testing market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global bloodstream infection testing market: Sample type movement & market share analysis.
  • Fig. 19 Global bloodstream infection testing market, for whole blood, 2018 - 2030 (USD Million)
  • Fig. 20 Global bloodstream infection testing market, for blood culture, 2018 - 2030 (USD Million)
  • Fig. 21 Global bloodstream infection testing market: Technology movement & market share analysis.
  • Fig. 22 Global bloodstream infection testing market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 23 Global bloodstream infection testing market, for mass spectroscopy, 2018 - 2030 (USD Million)
  • Fig. 24 Global bloodstream infection testing market, for in situ hybridization, 2018 - 2030 (USD Million)
  • Fig. 25 Global bloodstream infection testing market, for others, 2018 - 2030 (USD Million)
  • Fig. 26 Global bloodstream infection testing market: End-use movement & market share analysis.
  • Fig. 27 Global bloodstream infection testing market, for end-use, movement & market share analysis.
  • Fig. 28 Global bloodstream infection testing market, for hospitals & diagnostic centers, 2018 - 2030 (USD Million)
  • Fig. 29 Global bloodstream infection testing market, for custom laboratory service providers, 2018 - 2030 (USD Million)
  • Fig. 30 Global bloodstream infection testing market, for academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 31 Global bloodstream infection testing market, for others, 2018 - 2030 (USD Million)
  • Fig. 32 Regional marketplace: key takeaways
  • Fig. 33 Regional outlook, 2022 & 2030
  • Fig. 34 Global bloodstream infection testing market: region movement analysis.
  • Fig. 35 North America bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. key country dynamics
  • Fig. 37 U.S. bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada key country dynamics
  • Fig. 39 Canada bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 58 Japan key country dynamics
  • Fig. 59 Japan bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 60 China key country dynamics
  • Fig. 61 China bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 64 Australia key country dynamics
  • Fig. 65 Australia bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand key country dynamics
  • Fig. 67 Thailand bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea key country dynamics
  • Fig. 69 South Korea bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 73 Mexico key country dynamics
  • Fig. 74 Mexico bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina key country dynamics
  • Fig. 76 Argentina bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 77 Middle East and Africa bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa key country dynamics
  • Fig. 79 South Africa bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia key country dynamics
  • Fig. 81 Saudi Arabia bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 82 UAE key country dynamics
  • Fig. 83 UAE bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait key country dynamics
  • Fig. 85 Kuwait bloodstream infection testing market, 2018 - 2030 (USD Million)
  • Fig. 86 Company market position analysis
  • Fig. 87 Company/competition categorization
  • Fig. 88 Strategy mapping